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Abstract
Introduction: In the past, pertussis affected particularly children under 6 years of age, but recent
trends show that there is a shift toward the older age group. The clinical presentation can be
atypical in the adolescent age group, and the disease is often misdiagnosed.
Case presentation: We present a case of an 11-year-old male patient oriented to our unit with
anorexia, weight loss and persistent cough with nocturnal paroxysms for 4 weeks. He also
reported occasional wheezing and chest tightness. He denied fever, chills, myalgia, sore throat, or
rhinorrhea. The patient presented to his primary care physician 1 week prior with the same
complaint and was treated with amoxicillin and ebastine. Facing the persistence of the complaints
he was oriented to our unit in order to exclude tuberculosis. Further study confirmed Bordetella
pertussis infection and he started clarithromycin (15 mg/kg/day for 14 days). The patient's symptoms
resolved after two weeks. Two of the patient's family members have developed symptoms of
Bordetella pertussis infection and were treated after convenient study.
Conclusion: Cough is one of the most common complaints among children and its causes are
multiple. Active immunization and early diagnosis are crucial in the management of pertussis.
Introduction
In the past, pertussis affected particularly children under 6
years of age, but recent trends show that there is a shift
toward the older age group [1]. In Western countries,
approximately 10 to 12% of all pertussis cases occurred in
persons over 15 years of age [2]. The anticipation and
early diagnosis of these cases is important because the
affected adolescents and adults act as reservoirs of the dis-
ease to the vulnerable population of infants, for whom
the disease can be life threatening. The clinical presenta-
tion can be atypical in the adolescent age group, and the
disease is often misdiagnosed. With the availability of
polymerase chain reaction and serology, the disease can
be diagnosed even later in the disease course.
Case presentation
An 11-year-old male patient presented anorexia, weight
loss and persistent cough with nocturnal paroxysms for
the previous 4 weeks. He also reported occasional wheez-
ing and chest tightness. He denied fever, chills, myalgia,
sore throat, or rhinorrhea. The patient presented to his
primary care physician 1 week prior with the same com-
plaint, and was treated with amoxicillin, ebastine and
bronchodilator therapy. The patient's symptoms did not
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improve with this regimen. The cough became more fre-
quent, sometimes emetizing and with an end inspiratory
whoop. He was vaccinated according to the National Vac-
cine Program.
Facing the situation, the child was oriented to our unit in
order to exclude tuberculosis. Our health unit is responsi-
ble for the diagnosis and management of tuberculosis in
our region. On physical examination, the patient had an
oral temperature of 37°C and the oxygen saturation was
96% on room air. He was a well-developed, well-nour-
ished young boy with frequent, violent paroxysms of
cough. The mucous membranes were moist and the phar-
ynx was slightly injected without exudates. No mass or
adenopathy presented on examination of the neck. The
lungs presented diffuse crackles and expiratory wheezes.
The rest of the physical examination was unremarkable.
The blood analysis revealed an increased peripheral white
blood cell count with lymphocytosis and a normal bio-
chemistry, including normal C – reactive protein. The
chest radiograph showed a reinforcement of the perihilar
bonchovascular reticulum and heterogeneous infiltrates
on the inferior third of both lung fields (fig. 1).
At this point, the differential diagnosis included viral
upper respiratory infection, tuberculosis (as we have an
incidence rate of 26.4/100.000 inhabitants) [3] and per-
tussis. Tuberculin skin test was performed and read 72
hours later and was negative (0 mm). The child was hos-
pitalized, a gastric sample (as he has no sputum) was sent
for microbiological study and for detection of Mycobacte-
rium tuberculosis and Bordetella pertussis deoxyribonucleic
acid (DNA) by polymerase chain reaction (PCR) assays.
The PCR analysis of the patient's gastric sample was
reported to be positive for Bordetella pertussis DNA.
The patient received a prescription of clarithromycin (15
mg/kg/day for 14 days). All those who came in direct con-
tact with the case patient were advised to take a course of
clarithromycin as prophylaxis against pertussis infection.
The patient's symptoms resolved after two weeks. Two of
the patient's family members have developed symptoms
of Bordetella pertussis infection and were treated after con-
venient study.
Discussion
Cough is one of the most common complaints among
children and its causes are multiple [4]. This child also
presented anorexia and slight weight loss (1, 5 Kg during
4 weeks). Probably it was related to long-lasting clinical
symptoms and emetizing cough. In country with tubercu-
losis incidence of 29/100 000 inhabitants [5], and in the
presence of constitutional symptoms, tuberculosis must
be excluded. The child soon had weight gain after symp-
tom improvement.
Pertussis, an acute illness of respiratory tract remains
endemic in developed nations despite high vaccination
coverage [6]. While classical pertussis in the prevacine era
was primarily a childhood disease, today with widespread
vaccination, there has been a shift in the incidence of dis-
ease to adolescents and adults [7]. Indeed, infants are the
most vulnerable group with the highest rates of morbidity
and mortality, yet adolescents and adults now comprise a
significant percentage of cases and a conduit of infection
for the infants [7]. PCR, culture and serology are the main-
stay of the laboratory diagnosis of pertussis; however in
recent years PCR has become an increasingly more popu-
lar tool and has significantly contributed to the increasing
incidence of pertussis [7]. It is unusual to get positive PCR
on sputum specimen 4 weeks after cough start. Actually
the sensitivity of PCR decreases with the duration of
cough and among previously immunized individuals;
nevertheless it is a significantly more robust tool for diag-
nosis than culture in those in the later stages of disease. A
serology test can be a useful tool, particularly among older
patients presenting late in the course of their illness when
culture and PCR are negative.
In Portugal, pertussis vaccination was introduced by the
National Vaccine Program in 1965 and since 1967 the
number of reported cases has decreased [8]. In 2004 the
number of cases increased, as occurred in other European
countries. So, in 2006 the Advisory Committee on Immu-
nization Practices recommended that adolescents
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between the ages of 11 and 18 should receive another
dose of vaccine [9], although in Portugal pertussis vacci-
nation is still provided in five doses of DTaP (2, 4, 6, 18
months and 5–6 years) [7]. Active immunization and
early diagnosis are crucial in the management of pertussis.
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